Mepolizumab for the Treatment of Chronic Spontaneous Urticaria

NCT03494881 EARLY_PHASE1 COMPLETED Results posted

This is an exploratory study designed to generate preliminary data in evaluating the efficacy of Nucala in the treatment of chronic spontaneous urticaria.

Details

Lead sponsor	Mayo Clinic
Phase	EARLY_PHASE1
Status	COMPLETED
Enrolment	10
Start date	Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Chronic Spontaneous Urticaria

Interventions

• Nucala

Countries

United States